image

Develop

Our funding programs support early stage, Ohio-based companies to achieve success.

Cell Targeting, Inc.

Cell Targeting, Inc. is a preclinical-stage company developing a drug delivery platform utilizing a tissue-specific peptide targeting technology with broad therapeutic potential, including delivery of cardiovascular cellular therapies. In January 2011 the company technology was acquired by BioTime, Inc.

view all portfolio companies

Global Cardiovascular Innovation Center